))
CHIP, mCAs, and Cancer Risk: What We’re Learning
Manage episode 451291326 series 3582696
Indhold leveret af ACS Journal Cancer. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af ACS Journal Cancer eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
CANCER Section Editor and Host Dr. Courtney DiNardo welcomes Dr. Pinkal Desai, Dr. Koichi Takahashi, and Ms. Nehali Shah to discuss new research on the impact of clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal alterations (mCAs) on the risk and mortality of solid tumors like breast, lung, and colorectal cancer. Dr. Desai highlights findings from her recent study published in CANCER, while Dr. Takahashi and Ms. Shah share perspectives from their accompanying editorial. The episode explores the potential impact of these findings on clinical care and future research directions.
Read Dr. Desai’s article: https://bit.ly/CHIPandmCAsonSolidTumorRisk
Read the editorial by Dr. Takahashi and Ms. Shah: https://bit.ly/CHIPandmCAsEditorial
Music by Ivymusic, obtained from Pixabay.
10 episoder
Del
